Genentech to Present Data From One of the Most Comprehensive Oncology Portfolios at the 2021 ASCO Annual Meeting Showcasing Advancements for People Living With Cancer
— Data from the first positive Phase III study of a cancer immunotherapy in early, resected lung cancer — —...